Compare EC Healthcare with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -165.07% of over the last 5 years
- The company is Net-Debt Free
2
Negative results in Mar 26
3
With ROE of 3.51%, it has a Attractive valuation with a 0.27 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.68%
0%
50.68%
6 Months
15.79%
0%
15.79%
1 Year
-29.49%
0%
-29.49%
2 Years
-30.38%
0%
-30.38%
3 Years
-81.48%
0%
-81.48%
4 Years
-89.42%
0%
-89.42%
5 Years
-95.07%
0%
-95.07%
EC Healthcare for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.75%
EBIT Growth (5y)
-165.07%
EBIT to Interest (avg)
1.95
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
1.34
Tax Ratio
0.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
6.73%
ROE (avg)
9.02%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.27
EV to EBIT
-25.39
EV to EBITDA
0.79
EV to Capital Employed
0.26
EV to Sales
0.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.03%
ROE (Latest)
3.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
4,140.20
4,211.00
-1.68%
Operating Profit (PBDIT) excl Other Income
659.60
732.80
-9.99%
Interest
92.90
100.80
-7.84%
Exceptional Items
-246.80
-50.40
-389.68%
Consolidate Net Profit
-111.90
15.70
-812.74%
Operating Profit Margin (Excl OI)
6.90%
25.50%
-1.86%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is -1.68% vs 8.66% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -812.74% vs -85.33% in Mar 2024
About EC Healthcare 
EC Healthcare
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






